ZA897823B - Treatment for interstitial cystitis - Google Patents

Treatment for interstitial cystitis

Info

Publication number
ZA897823B
ZA897823B ZA897823A ZA897823A ZA897823B ZA 897823 B ZA897823 B ZA 897823B ZA 897823 A ZA897823 A ZA 897823A ZA 897823 A ZA897823 A ZA 897823A ZA 897823 B ZA897823 B ZA 897823B
Authority
ZA
South Africa
Prior art keywords
interstitial cystitis
treatment
naltrexone
nalmefene
administration
Prior art date
Application number
ZA897823A
Other languages
English (en)
Inventor
Fred P Sherman
P Sherman Fred
Original Assignee
Baker Cummins Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharma filed Critical Baker Cummins Pharma
Publication of ZA897823B publication Critical patent/ZA897823B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Threshing Machine Elements (AREA)
ZA897823A 1988-11-01 1989-10-16 Treatment for interstitial cystitis ZA897823B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/265,575 US4877791A (en) 1988-11-01 1988-11-01 Method of treatment for interestitial cystitis

Publications (1)

Publication Number Publication Date
ZA897823B true ZA897823B (en) 1990-07-25

Family

ID=23011021

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897823A ZA897823B (en) 1988-11-01 1989-10-16 Treatment for interstitial cystitis

Country Status (11)

Country Link
US (1) US4877791A (fr)
EP (1) EP0367533B1 (fr)
JP (1) JPH07556B2 (fr)
AT (1) ATE102830T1 (fr)
AU (1) AU623189B2 (fr)
CA (1) CA2001996C (fr)
DE (1) DE68913907T2 (fr)
DK (1) DK541189A (fr)
HK (1) HK119994A (fr)
NO (1) NO894295L (fr)
ZA (1) ZA897823B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4994466A (en) * 1990-06-14 1991-02-19 Baker Cummins Pharmaceuticals, Inc. Method of treatment for multiple sclerosis
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
AU5090796A (en) 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
WO2000044390A1 (fr) * 1999-02-01 2000-08-03 John Lezdey Traitement de la mastocytose gastro-intestinale et de la vessie
US6528520B2 (en) 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6262062B1 (en) 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
WO2002081477A1 (fr) * 2001-03-30 2002-10-17 Toray Industries, Inc. Derives morphinane 7-substitues et leur utilisation medicinale
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US6972291B2 (en) * 2002-07-02 2005-12-06 Bernstein Richard K Method for reducing food intake
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US20070243218A1 (en) * 2006-04-03 2007-10-18 Ellinghuysen Jerry A Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
EP2365759B1 (fr) * 2008-12-16 2018-03-07 Hill's Pet Nutrition, Inc. Composition alimentaire contenant un anti-oxydant contribuant à inhiber les voies de libération de l'histamine chez les animaux de compagnie
US20190358209A1 (en) * 2018-05-25 2019-11-28 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51145B1 (en) * 1980-03-07 1986-10-15 Efamol Ltd Pharmaceutical and dietary compositions
EP0245366A1 (fr) * 1985-10-29 1987-11-19 Baker Cummins Pharmaceuticals, Inc. Procede et composition pour bloquer des reactions allergiques provoquees par des antigenes
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases

Also Published As

Publication number Publication date
EP0367533A3 (fr) 1991-10-02
HK119994A (en) 1994-11-11
AU623189B2 (en) 1992-05-07
DE68913907D1 (de) 1994-04-21
JPH07556B2 (ja) 1995-01-11
DK541189D0 (da) 1989-10-30
ATE102830T1 (de) 1994-04-15
CA2001996C (fr) 1996-07-23
DK541189A (da) 1990-05-02
DE68913907T2 (de) 1994-06-23
NO894295D0 (no) 1989-10-27
JPH02188525A (ja) 1990-07-24
CA2001996A1 (fr) 1990-05-01
EP0367533B1 (fr) 1994-03-16
NO894295L (no) 1990-05-02
AU4385089A (en) 1990-05-10
EP0367533A2 (fr) 1990-05-09
US4877791A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
ZA899028B (en) Compound for treatment for autoimmune diseases
AU623189B2 (en) Method of treatment for interstitial cystitis
EP0377272A3 (fr) Utilisation de nalméfène ou naltrexone pour l'obtention d'un médicament destiné au traitement de l'inflammation dans l'arthrite ou dans des maladies inflammatoires associées
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
GEP20032965B (en) Pharmaceutical Compound
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
AU1189688A (en) Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
ATE78687T1 (de) Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
EP0319962A3 (fr) Dérivés de la pipéridinyl méthanol pour le traitement de l'anxiété
DK0583026T3 (fr)
EP0362847A3 (fr) Emploi de l'étopéritone pour obtenir une composition pharmaceutique pour le traitement de l'impotence chez l'homme
GR3018335T3 (en) Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease.
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
HUT59307A (en) Process for producing pharmaceutical compositions comprising zofenopril and suitable for treating arthritis
HU906436D0 (en) Process for the production of 3-substituted 2-oxyndole-derivatives
RO101041B1 (en) Reno-urinary affections treatment medication
UA30654A (uk) Спосіб лікування посттравматичних дисфункцій висково- нижньощелепового суглоба